Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

Products
Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics
Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

Information

Avanti Polar Lipids, part of Croda Pharma, develops innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics. We develop and manufacture highly specialised lipids used in Lipid Nanoparticle (LNP) delivery technology to solve the stability and delivery issues associated with mRNA-based vaccines and therapeutics. We have a wide portfolio of phospholipids, cationic lipids, PEG lipids and sterols. Our formulations division develops custom lipid-based drug delivery systems for a range of pharmaceutical applications. Our expertise is also in development, scale-up and manufacturing of lipids under cGMP. We also provide contract manufacturing services for proprietary lipids.
Main Categories
ExcipientsIntermediates, Fine and Specialty ChemicalsPharmaceutical Products / ATC coding
All Categories
Antiinfectives for Systemic useExcipientsIntermediates, Fine and Specialty ChemicalsPharmaceutical Products / ATC codingSpecialty ChemicalsVaccines
Croda Europe LimitedCroda Pharma is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations. The company is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein, and nucleic acid delivery platforms. With a wide range of solutions for both human and animal health markets, the pharmaceutical portfolio is unsurpassed in its excellence.

Log in

See all the content and easy-to-use features by logging in or registering!